Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

Description

The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.

Conditions

Lower Limb Injury

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.

Blood Flow Restriction Therapy in Lower Limb Extensor Injuries: A Randomized Controlled Double-Blind Study

Blood Flow Restriction Therapy in Lower Limb Extensor Injuries

Condition
Lower Limb Injury
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Must be at least 18 years of age and younger than 65 years of age
  • * ASA class I-II
  • * Diagnosed with a lower limb extensor injury (quadriceps tendon rupture, patella tendon rupture, patella fracture)
  • * Intention to receive physical therapy as standard of care
  • * Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia, etc.)
  • * Younger than 18 years of age or older than 65
  • * Any patient considered a vulnerable subject
  • * Patients with impaired circulation, peripheral vascular compromise, previous revascularization of the extremity, or severe hypertension
  • * Concomitant lower extremity traumatic injuries, delaying or precluding the subject's ability to participate in the therapy
  • * Immobile or use of mobile assistive device prior to injury
  • * No prior extensor injuries
  • * Patients with Sickle cell anemia or venous thromboembolism
  • * Patients with cancer or Lymphectomies
  • * Patients with increased intracranial pressure
  • * Patients with intention to receive standard therapy and not the study therapy

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

NYU Langone Health,

Guillem Gonzales-Lomas, MD, PRINCIPAL_INVESTIGATOR, NYU Langone

Study Record Dates

2025-12-01